AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

RecruitingNAAges 18 Years - 65 YearsAllInstitut de Myologie, France
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease. Current gait tests only consider the time factor and not the evolution of the patient's biomechanics, which may prove insufficient for patients whose symptoms generally progress slowly. Quantifying gait parameters in neuromuscular patients therefore appears necessary. This is why we propose to study markerless gait analysis in this population, which would allow for simple and effective monitoring of kinematic parameters without resorting to complex equipment incompatible with routine clinical practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
* All volunteers * Age between 18 and 65 * Ambulatory * Informed consent to participate in the study * Member of or beneficiary of a social security system * Volunteers with a neuromuscular disease * Confirmed diagnosis of a neuromuscular disease of genetic origin (medical document to be provided upon enrollment in the study with proof of diagnosis) belonging to the list above. * Ability to walk for 2 minutes without assistance. * Ability to stand up from a chair with armrests at least 3 times in 30 seconds. * Ability to climb an inclined plane independently or with assistance to access the movement analysis room. Exclusion Criteria * All volunteers * Individuals under guardianship, curatorship, or legal protection * Pregnant or breastfeeding women * Non-ambulatory individuals * Individuals with epilepsy * Skin conditions preventing the placement of VICON motion sensors * Asymptomatic volunteers * Unstable respiratory or cardiac problems * Neurological, musculoskeletal, or psychiatric problems * Volunteers with a neuromuscular disease * Recent trauma or serious falls (โ‰ค 6 months) * Individuals who have fallen more than twice in the past year and at least once in the past three months * Use of assistive devices such as rigid knee braces or walkers * Unstable cardiomyopathy * Individuals awaiting diagnosis Exclusion criteria * Inability to comply with the protocol requirements * Medical or social conditions that could interfere with the study, as determined by the coordinating investigator or co-investigators.
๐Ÿ’Š

What it tests

  • Gait analysis via video capture
๐Ÿ“

Where

1 site
Centre d'Exploration et d'ร‰valuation Neuromusculaire
Paris, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy